Hoshimoto Sojun, Hoshi Sayuri, Hishinuma Shoichi, Tomikawa Moriaki, Shirakawa Hirofumi, Ozawa Iwao, Wakamatsu Saho, Hoshi Nobuo, Hirabayashi Kaoru, Ogata Yoshiro
a Department of Hepato-Biliary-Pancreatic Surgery , Tochigi Cancer Center , Utsunomiya , Japan.
b Department of Pathology , Tochigi Cancer Center , Utsunomiya , Japan.
Scand J Gastroenterol. 2017 Apr;52(4):425-430. doi: 10.1080/00365521.2016.1273383. Epub 2016 Dec 30.
The purpose of this study was to evaluate the association of the proliferative ability of squamous cell carcinoma (SCC) component with its proportion and tumor progression in adenosquamous carcinoma (ASC) in the biliary tract.
Nine patients with ASC in the biliary tract (four each in the gallbladder and the extrahepatic bile duct and one in the ampulla of Vater) who underwent surgical resection were retrospectively reviewed.
The proportion of the SCC component in the primary sites ranged from 30% to 95%. The Ki-67 index of the SCC component was higher than that of the adenocarcinoma component in all cases, regardless of the component ratio in the patients' primary lesions. Predominance of the SCC component in the advancing region of the tumor, in angiolymphatic invasion and in perineural invasion was observed in most of the cases. The component ratio in metastatic lymph nodes differed from that in the corresponding primary lesions in all six cases with lymph node metastasis. Among these cases, the proportion of the SCC component was increased in the metastatic lymph nodes compared with that in the corresponding primary lesion in two cases, whereas the proportion was decreased in four cases.
The SCC component of ASC in the biliary tract displayed a relatively higher proliferative ability, which might be associated with local invasiveness. However, not only the high proliferative ability of the SCC component but also other biological factors might contribute to tumor progression and metastasis in ASC of the biliary tract.
本研究旨在评估胆管腺鳞癌(ASC)中鳞状细胞癌(SCC)成分的增殖能力与其比例及肿瘤进展之间的关系。
回顾性分析9例行手术切除的胆管ASC患者(胆囊4例、肝外胆管4例、Vater壶腹1例)。
原发部位SCC成分的比例为30%至95%。所有病例中,SCC成分的Ki-67指数均高于腺癌成分,与患者原发灶中的成分比例无关。多数病例中,肿瘤进展区域、血管淋巴管浸润及神经周围浸润中SCC成分占优势。6例有淋巴结转移的病例中,转移淋巴结中的成分比例与相应原发灶不同。其中,2例转移淋巴结中SCC成分的比例较相应原发灶增加,4例则降低。
胆管ASC中的SCC成分显示出相对较高的增殖能力,这可能与局部侵袭性有关。然而,不仅SCC成分的高增殖能力,其他生物学因素也可能导致胆管ASC的肿瘤进展和转移。